Back to funds

GREAT POINT PARTNERS LLC

Updated 6 days ago

Managed by Great Point Partners Llc • Latest filing Q3 2026

Portfolio value
$418.5M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
91.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$308.4M
Q1 2026$435.1M
Q2 2026$529.1M
Q3 2026$418.5M

Top holdings

45 positions as of Q3 2026

View filing
H

IMMUNITYBIO INC

Value
$28.3M
Shares
3.00M
% Port
6.77%
V

VERA THERAPEUTICS INC

Value
$26.1M
Shares
808.7K
% Port
6.24%
V

VOR BIOPHARMA INC

Value
$21.5M
Shares
1.13M
% Port
5.14%
A

AMYLYX PHARMACEUTICALS INC

Value
$20.4M
Shares
700.0K
% Port
4.87%
S

SAGIMET BIOSCIENCES INC

Value
$19.4M
Shares
1.96M
% Port
4.63%
D

DEFINIUM THERAPEUTICS INC

Value
$19.4M
Shares
508.7K
% Port
4.63%
I

IONIS PHARMACEUTICALS INC

Value
$18.8M
Shares
420.0K
% Port
4.48%
G

GENMAB A/S

Value
$18.7M
Shares
525.0K
% Port
4.48%
S

SOL-GEL TECHNOLOGIES LTD

Value
$17.8M
Shares
239.2K
% Port
4.25%
Z

ZURA BIO LTD

Value
$17M
Shares
4.08M
% Port
4.05%
L

LB PHARMACEUTICALS INC

Value
$15.8M
Shares
410.4K
% Port
3.76%
A

ABIVAX SA

Value
$15.3M
Shares
155.0K
% Port
3.67%
A

ANNEXON INC

Value
$14.8M
Shares
3.50M
% Port
3.54%
B

BELITE BIO INC

Value
$12.7M
Shares
75.0K
% Port
3.04%
E

EUPRAXIA PHARMACEUTICALS INC

Value
$10.9M
Shares
1.20M
% Port
2.61%
N

NEKTAR THERAPEUTICS

Value
$10.6M
Shares
175.0K
% Port
2.53%
M

MOONLAKE IMMUNOTHERAPEUTICS

Value
$10M
Shares
855.8K
% Port
2.39%
?
18.N/A

CLIMB BIO INC

Value
$9.2M
Shares
800.0K
% Port
2.19%
A

ABCELLERA BIOLOGICS INC

Value
$8.8M
Shares
600.0K
% Port
2.09%
N

NEUROGENE INC

Value
$8.3M
Shares
300.0K
% Port
1.99%

Explore